| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 76.32 | 5.5% | 0.0% |
| Total Income | 76.32 | 5.5% | 0.0% |
| Expenditure | 93.83 | 20.4% | 4.2% |
| PBT | — | ||
| Net Profit | -22.23 | 45.8% | 50.9% |
| OPM | -22.94% | 23.01pp | 5.02pp |
| NPM | -29.13% | 21.64pp | 9.84pp |
| EPS | -0.32 | 45.8% | 33.3% |
Health Catalyst Reports Q3 2025 Revenue of $76.3 Million
04 May 2026 · 4 May, 7:33 am
Summary
Health Catalyst reported its Q3 2025 financial results, with total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, both exceeding the company's quarterly guidance. The company's focus on high-impact solutions and commitment to client understanding contributed to these results. Health Catalyst reaffirmed its full-year 2025 guidance, projecting total revenue of approximately $310 million and Adjusted EBITDA of approximately $41 million. The company believes its strategic focus, cost management, and targeted investments will drive sustained value for clients and shareholders.
Key Highlights
- 1
Health Catalyst reported total revenue of $76.3 million for the third quarter of 2025.
- 2
Adjusted EBITDA for Q3 2025 was $12.0 million, exceeding quarterly guidance.
- 3
Adjusted Gross Profit increased to $40.1 million, representing an Adjusted Gross Margin of 53%.
- 4
The company reaffirmed its full-year 2025 revenue guidance of approximately $310 million.
- 5
Health Catalyst expects approximately $73.5 million in total revenue for the fourth quarter of 2025.
- 6
The company anticipates Adjusted EBITDA of approximately $13.4 million for Q4 2025.
- 7
For the full year 2025, Health Catalyst expects Adjusted EBITDA of approximately $41 million.
Management Comments
Dan Burton
“For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure. By focusing on high-impact solutions with proven ROI and maintaining a commitment to understanding and evolving with our clients, we have reaffirmed our full-year 2025 guidance. We believe our commitment to strategic focus, cost management, and targeted investments positions us to drive sustained value for our clients and shareholders.”
Informational and educational content only. Not investment advice.